On Tuesday, Cogent Biosciences Inc (NASDAQ: COGT) was 1.22% up from the session before settling in for the closing price of $12.3. A 52-week range for COGT has been $3.72 – $12.97.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 10.02% over the last five years. When this article was written, the company’s average yearly earnings per share was at 11.15%. With a float of $126.05 million, this company’s outstanding shares have now reached $163.81 million.
The firm has a total of 205 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Cogent Biosciences Inc (COGT) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Cogent Biosciences Inc stocks. The insider ownership of Cogent Biosciences Inc is 23.05%, while institutional ownership is 71.14%. The most recent insider transaction that took place on Jul 10 ’25, was worth 24,999,993. In this transaction Director of this company bought 2,777,777 shares at a rate of $9.00, taking the stock ownership to the 9,003,418 shares. Before that another transaction happened on Jan 14 ’25, when Company’s Chief Commercial Officer bought 43,750 for $7.60, making the entire transaction worth $332,412. This insider now owns 45,848 shares in total.
Cogent Biosciences Inc (COGT) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.52 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 11.15% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 30.24% during the next five years compared to 10.02% growth over the previous five years of trading.
Cogent Biosciences Inc (NASDAQ: COGT) Trading Performance Indicators
You can see what Cogent Biosciences Inc (COGT) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 5.13.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.38, a number that is poised to hit -0.59 in the next quarter and is forecasted to reach -1.92 in one year’s time.
Technical Analysis of Cogent Biosciences Inc (COGT)
Analysing the last 5-days average volume posted by the [Cogent Biosciences Inc, COGT], we can find that recorded value of 3.05 million was better than the volume posted last year of 2.04 million. As of the previous 9 days, the stock’s Stochastic %D was 83.14%.
During the past 100 days, Cogent Biosciences Inc’s (COGT) raw stochastic average was set at 94.38%, which indicates a significant increase from 91.03% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.81 in the past 14 days, which was higher than the 0.50 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.42, while its 200-day Moving Average is $7.99. Now, the first resistance to watch is $12.79. This is followed by the second major resistance level at $13.13. The third major resistance level sits at $13.52. If the price goes on to break the first support level at $12.06, it is likely to go to the next support level at $11.67. Should the price break the second support level, the third support level stands at $11.33.
Cogent Biosciences Inc (NASDAQ: COGT) Key Stats
There are 113,856K outstanding shares of the company, which has a market capitalization of 2.04 billion. As of now, sales total 0 K while income totals -255,860 K. Its latest quarter income was 0 K while its last quarter net income were -71,990 K.
